SOAT1 and myeloproliferative disorder: We have recently shown that both mutant and non-mutant hematopoietic cells are the source of pro-inflammatory cytokines in MPN mouse models and patients and that JAK-STAT signaling in mutant and non-mutant cells has to be inhibited in order to achieve therapeutic response (Kleppe et al., 2015b).